Meral Beksac

45PUBLICATIONS
296CO-AUTHORS
Haematological tumoursMedical mycologyNanomedicineGenetic immunologyCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (45)

|Sep 25, 2026
Daratumumab Plus Bortezomib, Lenalidomide, and Dexamethasone in Newly Diagnosed Multiple Myeloma: Transplant-Ineligible Subgroup Analysis of CEPHEUS.

|Aug 16, 2026
How to treat hepatic extra-medullary involvement of myeloma: a case report and review of literature.

|Jun 03, 2026
Daratumumab in transplant-ineligible or -deferred newly diagnosed multiple myeloma: minimal residual disease in CEPHEUS.

|May 27, 2026
Innate immunogenetic synergy between KIR and Neanderthal-derived OAS variants predicts COVID-19 outcomes.

|May 12, 2026
Daratumumab-bortezomib-cyclophosphamide-dexamethasone for newly diagnosed amyloidosis: ANDROMEDA final survival analysis.

|Mar 26, 2026
Linvoseltamab versus real-world International Myeloma Working Group standard-of-care in triple-class exposed relapsed/refractory multiple myeloma.

Shaji Kumar, Sundar Jagannath, Katja C Weisel

Pageof 8

Frequent Collaborators

8 joint publications

Güldane Cengiz Seval

7 joint publications

Patrick J Hayden

6 joint publications

Donal P McLornan

6 joint publications

Maria-Victoria Mateos